HealthEquity HQY Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price at other companies
Other financials
Where this comes from
Reported directly by HealthEquity in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice.
The official record: HealthEquity’s 10-Q, filed May 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about HealthEquity's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, weighted average exercise price.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is HealthEquity's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, weighted average exercise price?
- HealthEquity (HQY) reported share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, weighted average exercise price of $50.01 in Q1 2026.
- How has HealthEquity's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, weighted average exercise price changed year-over-year?
- HealthEquity's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, weighted average exercise price increased by 0.2% year-over-year, from $49.91 to $50.01.